Relationship between frailty and lower urinary tract symptoms among community-dwelling adults
- PMID: 31642610
- DOI: 10.1111/luts.12292
Relationship between frailty and lower urinary tract symptoms among community-dwelling adults
Abstract
Objectives: To evaluate the relationship between frailty and lower urinary tract symptoms (LUTS), the association of frailty and LUTS remains unclear.
Methods: This cross-sectional study investigated LUTS and frailty in 710 individuals (249 men and 461 women, aged ≥60 years) who participated in the Iwaki Health Promotion Project between 2014 and 2015 in Hirosaki, Japan. Parameters of frailty were compared for individuals with mild and moderate to severe symptoms of LUTS. The International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS) were used to evaluate LUTS. Frailty was evaluated by the frailty phenotype (FP), modified frailty index (mFI), and frailty discriminant score (FDS). The influence of frailty on LUTS was investigated by multivariate logistic regression analyses.
Results: Frailty parameters of age, renal function, and lower physical activity were significantly associated with severity of IPSS and OABSS. FP and mFI were significantly associated with severity of OABSS and IPSS, respectively. The FDS was significantly associated with severity of IPSS and OABSS. FP, mFI, and FDS were significantly associated with severity of nocturia. Multivariate logistic regression analyses revealed that FDS was independently associated with the severity of IPSS, OABSS, and nocturia, whereas FP and mFI were significantly associated with the severity of nocturia alone.
Conclusions: Individuals with LUTS are potentially frailer than those without LUTS. Although the influence of frailty on LUTS is different depending on the measurement tool, attention for frailty is necessary for subjects with LUTS.
Keywords: IPSS; Nocturia; frailty; lower urinary tract symptoms.
© 2019 John Wiley & Sons Australia, Ltd.
Similar articles
-
Association between oral frailty and lower urinary tract symptoms among middle-aged and older adults in community-dwelling individuals: a cross-sectional study.Int Urol Nephrol. 2024 Jun;56(6):1803-1810. doi: 10.1007/s11255-023-03878-6. Epub 2024 Jan 12. Int Urol Nephrol. 2024. PMID: 38216828
-
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.BJU Int. 2019 May;123(5):877-884. doi: 10.1111/bju.14535. Epub 2018 Oct 15. BJU Int. 2019. PMID: 30216623
-
Relationship between lower urinary tract symptoms and frailty.Int J Urol. 2023 Jul;30(7):606-613. doi: 10.1111/iju.15187. Epub 2023 Apr 23. Int J Urol. 2023. PMID: 37087744
-
LUTS in Older Adults: Definitions, Comorbidity Impact, Patient Priorities, and Treatment Strategies for Managing Daytime and/or Nighttime Symptoms - ICI-RS 2024.Neurourol Urodyn. 2025 Mar;44(3):592-600. doi: 10.1002/nau.25624. Epub 2024 Nov 11. Neurourol Urodyn. 2025. PMID: 39526631 Review.
-
Is the insomnia phenotype the common denominator in LUTS during transition periods? An expert NOPIA research group review.Neurourol Urodyn. 2024 Jun;43(5):1134-1146. doi: 10.1002/nau.25372. Epub 2024 Jan 30. Neurourol Urodyn. 2024. PMID: 38289321 Review.
Cited by
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).Int J Clin Oncol. 2021 Jan;26(1):199-206. doi: 10.1007/s10147-020-01798-4. Epub 2020 Oct 16. Int J Clin Oncol. 2021. PMID: 33079283
-
Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.BJUI Compass. 2021 Oct 5;3(2):162-168. doi: 10.1002/bco2.114. eCollection 2022 Mar. BJUI Compass. 2021. PMID: 35474730 Free PMC article.
-
Longitudinal Associations between Concurrent Changes in Phenotypic Frailty and Lower Urinary Tract Symptoms among Older Men.J Frailty Aging. 2023;12(2):117-125. doi: 10.14283/jfa.2022.33. J Frailty Aging. 2023. PMID: 36946708 Free PMC article.
-
Low lean mass is associated with lower urinary tract symptoms in US men from the 2005-2006 national health and nutrition examination survey dataset.Aging (Albany NY). 2021 Sep 2;13(17):21421-21434. doi: 10.18632/aging.203480. Epub 2021 Sep 2. Aging (Albany NY). 2021. PMID: 34475271 Free PMC article.
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).Transl Androl Urol. 2021 Mar;10(3):1143-1151. doi: 10.21037/tau-20-1351. Transl Androl Urol. 2021. PMID: 33850749 Free PMC article.
References
REFERENCES
-
- Yamanishi T, Asakura H, Seki N, Tokunaga S. Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: a multicenter, randomized, open-label, controlled trial (DIrecT Study). Int J Urol. 2017;24(7):525-531.
-
- Fukumoto K, Nagai A, Hara R, Fujii T, Miyaji Y. Tadalafil for male lower urinary tract symptoms improves endothelial function. Int J Urol. 2017;24(3):206-210.
-
- Homma Y, Gotoh M, Kawauchi A, et al. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia. Int J Urol. 2017;24(10):716-729.
-
- Takeda M, Yokoyama O, Yoshida M, et al. Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized, placebo-controlled, cross-over study. Int J Urol. 2017;24(7):539-547.
-
- Matsumoto T, Hatakeyama S, Imai A, et al. Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan. BJU Int. 2019;123(5):877-884.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical